AstraZeneca (NASDAQ:AZN) stock received a positive assessment from UBS, as analyst Matthew Weston upgraded the pharmaceutical giant's rating from Neutral to Buy. The upgrade was accompanied by a ...
Mostly sunny. The chance of fog early this morning. Medium chance of showers this evening. The chance of a thunderstorm this evening, possibly severe. Light winds. Fire Danger - High Sun protection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback